.svg){kind=small}
Market Insights Snapshot
Happy Hounds CBD concentrated 84.34% of September 2026 sales in Edible, with Tincture & Sublingual at 15.66%, indicating a narrow category mix. Edible declined 23.82% year over year and 9.66% month over month, while Tincture & Sublingual slipped 0.49% year over year and 0.88% month over month, pulling total brand sales down 20.92% year over year despite a 1.24% lift in average price to $34.90. The Edible average price sat at $33.30 versus $47.07 in Tincture & Sublingual, and the lack of an Edible rank in New York suggests distribution or velocity gaps; together these shifts imply overexposure to a contracting Edible base is the primary drag rather than price-driven churn.
The mix shift implies a positioning anchored in value-oriented Edibles that are underperforming peers on velocity, given a 9.66% month-over-month contraction in the dominant category alongside a comparatively stable 0.88% month-over-month dip in Tincture & Sublingual. With Edible down 23.82% year over year versus a 0.49% year-over-year decline in Tincture & Sublingual, the portfolio skews toward a higher-elasticity segment, which likely amplifies promotional pressure and limits rank visibility in New York; the implication is that mix diversification toward Tincture & Sublingual or format extensions within Edibles would reduce sensitivity to category-wide declines and improve baseline velocity.
Competitive Landscape
Happy Hounds CBD is ranked #95 in NY Edible in September 2026, down 18 positions year over year from #77, and 8 positions lower than June 2026’s #87, while still sitting 23 places below its peak of #72 from September 2024; in contrast, Wyld moved up from #3 to #2 with a 13.95% YoY sales increase and Off Hours slipped from #1 to #3 with a 28.16% YoY sales decline, indicating that relative share is concentrating among top ranks as mid-pack brands lose ground. With Gron / Grön holding steady at #4 alongside a 12.19% YoY sales gain and Ayrloom staying at #5 despite a 15.10% YoY sales drop, the spread between ranks suggests that incremental percentage shifts among leaders translate into multi-rank swings for lower-tier players; this rank trajectory implies Happy Hounds CBD faces a widening ladder where recovering even 10–15 ranks likely requires outperforming double-digit percentage growth seen near the top.
Notable Products
CBD Calm + Joint Bacon Strips Chews 30-Pack (150mg CBD) delivered the largest month-over-month move at +147.8% and climbed to rank 2, while CBD Calm Peanut Butter Chews 30-Pack (150mg CBD) fell -44.4% yet still held rank 1. Two of the top four SKUs are Edibles, indicating a concentration in chewable formats, and the leading chew brought in $2,535. With CBD Calm Extra Strength Drops (500mg CBD) up 8.4% at rank 3 but CBD Calm + Coat Salmon Peanut Butter Tincture (250mg CBD) down -37.3% at rank 4, the mix tilts toward functional chews over tinctures. The pattern implies Happy Hounds CBD is pivoting toward condition-focused Edible formats as the commercial priority.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
